Skip to content

Drug interactions

Conivaptan + Eslicarbazepine

Severity: Moderate

Conivaptan and Eslicarbazepine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Conivaptan is a CYP3A4 substrate, and eslicarbazepine could lower its concentration through enzyme induction. This could reduce its effect in raising serum sodium.

What this interaction means in plain words

Conivaptan and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

CYP3A4 induction by eslicarbazepine increases conivaptan metabolism.

What to do

Monitor serum sodium frequently during conivaptan infusion. Adjust therapy if the sodium response is inadequate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Conivaptan and Eslicarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Conivaptan with Eslicarbazepine?

MediHelp rates the interaction as moderate. Conivaptan and Eslicarbazepine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Conivaptan is a CYP3A4 substrate, and eslicarbazepine could lower its concentration through enzyme induction. This could reduce its effect in raising serum sodium.

How serious is the interaction between Conivaptan and Eslicarbazepine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum sodium frequently during conivaptan infusion. Adjust therapy if the sodium response is inadequate.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in